Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 12 von 91

Details

Autor(en) / Beteiligte
Titel
DADFN: dynamic adaptive deep fusion network based on imaging genomics for prediction recurrence of lung cancer
Ist Teil von
  • Physics in medicine & biology, 2023-04, Vol.68 (7), p.75007
Ort / Verlag
England: IOP Publishing
Erscheinungsjahr
2023
Quelle
MEDLINE
Beschreibungen/Notizen
  • . Recently, imaging genomics has increasingly shown great potential for predicting postoperative recurrence of lung cancer patients. However, prediction methods based on imaging genomics have some disadvantages such as small sample size, high-dimensional information redundancy and poor multimodal fusion efficiency. This study aim to develop a new fusion model to overcome these challenges. . In this study, a dynamic adaptive deep fusion network (DADFN) model based on imaging genomics is proposed for predicting recurrence of lung cancer. In this model, the 3D spiral transformation is used to augment the dataset, which better retains the 3D spatial information of the tumor for deep feature extraction. The intersection of genes screened by LASSO, F-test and CHI-2 selection methods is used to eliminate redundant data and retain the most relevant gene features for the gene feature extraction. A dynamic adaptive fusion mechanism based on the cascade idea is proposed, and multiple different types of base classifiers are integrated in each layer, which can fully utilize the correlation and diversity between multimodal information to better fuse deep features, handcrafted features and gene features. . The experimental results show that the DADFN model achieves good performance, and its accuracy and AUC are 0.884 and 0.863, respectively. This indicates that the model is effective in predicting lung cancer recurrence. . The proposed model has the potential to help physicians to stratify the risk of lung cancer patients and can be used to identify patients who may benefit from a personalized treatment option.
Sprache
Englisch
Identifikatoren
ISSN: 0031-9155
eISSN: 1361-6560
DOI: 10.1088/1361-6560/acc168
Titel-ID: cdi_crossref_primary_10_1088_1361_6560_acc168

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX